Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 8 | 2020 | 22 | 2.390 |
Why?
|
| Cartilage, Articular | 6 | 2019 | 76 | 1.880 |
Why?
|
| Whole-Body Irradiation | 4 | 2015 | 53 | 1.580 |
Why?
|
| Knee Joint | 3 | 2019 | 142 | 1.540 |
Why?
|
| Weightlessness | 4 | 2020 | 8 | 1.420 |
Why?
|
| Hindlimb Suspension | 4 | 2019 | 11 | 1.420 |
Why?
|
| Gait | 2 | 2019 | 142 | 0.850 |
Why?
|
| Animals | 27 | 2020 | 7541 | 0.810 |
Why?
|
| Mice, Inbred C57BL | 13 | 2020 | 767 | 0.660 |
Why?
|
| Bone and Bones | 5 | 2014 | 94 | 0.630 |
Why?
|
| Hip Joint | 1 | 2019 | 59 | 0.630 |
Why?
|
| Mice | 14 | 2020 | 2484 | 0.600 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2019 | 81 | 0.580 |
Why?
|
| Weight-Bearing | 2 | 2016 | 40 | 0.570 |
Why?
|
| Anus Neoplasms | 1 | 2016 | 13 | 0.560 |
Why?
|
| Femur Neck | 1 | 2016 | 21 | 0.560 |
Why?
|
| Pelvis | 1 | 2016 | 61 | 0.540 |
Why?
|
| Arthritis | 1 | 2016 | 40 | 0.540 |
Why?
|
| Sarcoma, Experimental | 1 | 2016 | 4 | 0.530 |
Why?
|
| Spasm | 1 | 2016 | 6 | 0.530 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 23 | 0.530 |
Why?
|
| Ribs | 1 | 2016 | 44 | 0.510 |
Why?
|
| Radiometry | 1 | 2015 | 40 | 0.510 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 60 | 0.500 |
Why?
|
| Joints | 1 | 2014 | 13 | 0.480 |
Why?
|
| Angiotensin I | 1 | 2016 | 241 | 0.460 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 519 | 0.430 |
Why?
|
| Peptide Fragments | 1 | 2016 | 399 | 0.430 |
Why?
|
| Radiosurgery | 1 | 2016 | 356 | 0.410 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1022 | 0.400 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 412 | 0.400 |
Why?
|
| Osteogenesis | 3 | 2019 | 82 | 0.380 |
Why?
|
| Bone Density | 4 | 2018 | 205 | 0.370 |
Why?
|
| Etidronic Acid | 1 | 2009 | 3 | 0.350 |
Why?
|
| Male | 14 | 2020 | 19165 | 0.340 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 23 | 0.340 |
Why?
|
| Mitochondria | 2 | 2020 | 187 | 0.330 |
Why?
|
| Osteoporosis | 1 | 2009 | 70 | 0.320 |
Why?
|
| Osteoclasts | 1 | 2008 | 22 | 0.320 |
Why?
|
| Tibia | 4 | 2016 | 56 | 0.310 |
Why?
|
| X-Ray Microtomography | 3 | 2019 | 41 | 0.310 |
Why?
|
| Alligators and Crocodiles | 2 | 2005 | 3 | 0.300 |
Why?
|
| Locomotion | 2 | 2005 | 31 | 0.290 |
Why?
|
| Rats | 3 | 2016 | 1595 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 918 | 0.280 |
Why?
|
| Glycosaminoglycans | 3 | 2016 | 20 | 0.280 |
Why?
|
| Cell Proliferation | 1 | 2008 | 604 | 0.260 |
Why?
|
| Tail | 1 | 2004 | 5 | 0.230 |
Why?
|
| Time Factors | 2 | 2019 | 2149 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Femur | 3 | 2016 | 74 | 0.220 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Osteoarthritis | 2 | 2014 | 79 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Transients and Migrants | 1 | 2016 | 290 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Swine | 4 | 2019 | 215 | 0.210 |
Why?
|
| Chondrocytes | 2 | 2013 | 74 | 0.210 |
Why?
|
| Oxidative Stress | 2 | 2020 | 231 | 0.200 |
Why?
|
| Punctures | 2 | 2019 | 33 | 0.200 |
Why?
|
| Hindlimb | 2 | 2016 | 54 | 0.190 |
Why?
|
| Protons | 2 | 2012 | 23 | 0.180 |
Why?
|
| Stress, Physiological | 1 | 2020 | 55 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 48 | 0.180 |
Why?
|
| Proteome | 1 | 2020 | 39 | 0.180 |
Why?
|
| Genomics | 1 | 2020 | 85 | 0.180 |
Why?
|
| Spacecraft | 1 | 2019 | 3 | 0.170 |
Why?
|
| Adaptation, Ocular | 1 | 2019 | 1 | 0.170 |
Why?
|
| Blood-Retinal Barrier | 1 | 2019 | 1 | 0.170 |
Why?
|
| Extremities | 1 | 2019 | 50 | 0.170 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 122 | 0.170 |
Why?
|
| Organ Size | 2 | 2018 | 218 | 0.170 |
Why?
|
| Tissue Transplantation | 1 | 2019 | 16 | 0.170 |
Why?
|
| Osteoblasts | 2 | 2019 | 45 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 40 | 0.170 |
Why?
|
| Menisci, Tibial | 1 | 2019 | 25 | 0.170 |
Why?
|
| Female | 8 | 2019 | 19959 | 0.170 |
Why?
|
| Retina | 1 | 2019 | 61 | 0.160 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 50 | 0.160 |
Why?
|
| Amnion | 1 | 2019 | 37 | 0.160 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 42 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 23 | 0.150 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 182 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 37 | 0.150 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 101 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 115 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 538 | 0.140 |
Why?
|
| Macaca mulatta | 1 | 2018 | 305 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 495 | 0.140 |
Why?
|
| Body Weight | 2 | 2016 | 310 | 0.140 |
Why?
|
| Middle Aged | 4 | 2017 | 11817 | 0.140 |
Why?
|
| Humans | 9 | 2020 | 32005 | 0.140 |
Why?
|
| Probability | 1 | 2016 | 158 | 0.140 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 111 | 0.140 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 415 | 0.140 |
Why?
|
| Rib Fractures | 1 | 2016 | 21 | 0.130 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 101 | 0.130 |
Why?
|
| Muscle Neoplasms | 1 | 2016 | 8 | 0.130 |
Why?
|
| International Agencies | 1 | 2015 | 10 | 0.130 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 48 | 0.130 |
Why?
|
| Fractures, Bone | 1 | 2017 | 148 | 0.130 |
Why?
|
| Radiobiology | 1 | 2015 | 5 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2015 | 41 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 93 | 0.130 |
Why?
|
| Weightlessness Simulation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Oncostatin M | 1 | 2015 | 2 | 0.130 |
Why?
|
| Particle Accelerators | 1 | 2015 | 7 | 0.130 |
Why?
|
| Fibrosis | 1 | 2016 | 120 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 1328 | 0.130 |
Why?
|
| Reference Values | 1 | 2016 | 246 | 0.130 |
Why?
|
| Radiation Injuries | 1 | 2016 | 76 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2015 | 52 | 0.130 |
Why?
|
| Research | 1 | 2015 | 74 | 0.130 |
Why?
|
| Random Allocation | 1 | 2016 | 226 | 0.130 |
Why?
|
| Collagen | 1 | 2016 | 225 | 0.130 |
Why?
|
| Adult | 3 | 2016 | 9345 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2019 | 898 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2016 | 463 | 0.120 |
Why?
|
| Nanotechnology | 1 | 2014 | 16 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2015 | 91 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2015 | 100 | 0.120 |
Why?
|
| Logistic Models | 1 | 2016 | 781 | 0.120 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 133 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 743 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 582 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 471 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 4 | 0.110 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Fibronectins | 1 | 2013 | 36 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 951 | 0.110 |
Why?
|
| Aged | 4 | 2019 | 10301 | 0.110 |
Why?
|
| X-Rays | 2 | 2013 | 5 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2012 | 32 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 84 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2013 | 682 | 0.100 |
Why?
|
| Cell Survival | 1 | 2012 | 284 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 3990 | 0.100 |
Why?
|
| DNA | 1 | 2012 | 226 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2013 | 833 | 0.090 |
Why?
|
| Cosmic Radiation | 1 | 2009 | 14 | 0.080 |
Why?
|
| Humerus | 1 | 2009 | 32 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 109 | 0.080 |
Why?
|
| Rabbits | 2 | 2019 | 197 | 0.080 |
Why?
|
| Apoptosis | 2 | 2020 | 360 | 0.080 |
Why?
|
| Cell Line | 2 | 2019 | 435 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2019 | 469 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 23 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2004 | 39 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 51 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2019 | 780 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 392 | 0.050 |
Why?
|
| Cytokines | 1 | 2004 | 256 | 0.050 |
Why?
|
| Radiography | 2 | 2018 | 376 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2020 | 81 | 0.050 |
Why?
|
| Biological Transport | 1 | 2020 | 69 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 43 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 167 | 0.050 |
Why?
|
| Muscles | 1 | 2020 | 62 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2020 | 75 | 0.040 |
Why?
|
| Smell | 1 | 2020 | 48 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 105 | 0.040 |
Why?
|
| Bone Substitutes | 1 | 2019 | 9 | 0.040 |
Why?
|
| Ecological Systems, Closed | 1 | 2019 | 1 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2019 | 6 | 0.040 |
Why?
|
| United States | 2 | 2019 | 3939 | 0.040 |
Why?
|
| Crystallins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Aquaporin 4 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2019 | 19 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 28 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2019 | 33 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 51 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 41 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 40 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2019 | 34 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 125 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2019 | 73 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 245 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 94 | 0.040 |
Why?
|
| Needles | 1 | 2018 | 31 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2019 | 189 | 0.040 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2018 | 19 | 0.040 |
Why?
|
| Medicare | 1 | 2019 | 206 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 92 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 472 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 314 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 185 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 1 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2015 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2015 | 45 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 105 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 247 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2019 | 656 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2013 | 9 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 51 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 3876 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3509 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3306 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2009 | 84 | 0.020 |
Why?
|
| Synchrotrons | 1 | 2008 | 3 | 0.020 |
Why?
|
| Sunlight | 1 | 2008 | 17 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 51 | 0.020 |
Why?
|
| Electromyography | 1 | 2005 | 59 | 0.020 |
Why?
|